title: Cushing's syndrome due to antiretroviral-budesonide interaction.
authors.forename: Jonathan K
authors.initials: JK
authors.lastname: Frankel
authors.forename: Clifford D
authors.initials: CD
authors.lastname: Packer
mesh_terms: D000368:Aged; D000069446:Atazanavir Sulfate; D019819:Budesonide / Q000009:adverse effects* / Q000493:pharmacokinetics; D003480:Cushing Syndrome / Q000139:chemically induced*; D051544:Cytochrome P-450 CYP3A / Q000378:metabolism*; D065692:Cytochrome P-450 CYP3A Inhibitors; D004347:Drug Interactions; D005938:Glucocorticoids / Q000009:adverse effects / Q000493:pharmacokinetics; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000009:adverse effects / Q000494:pharmacology; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology; D019438:Ritonavir / Q000009:adverse effects / Q000494:pharmacology
chemical_list: D065692:Cytochrome P-450 CYP3A Inhibitors; D005938:Glucocorticoids; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; D019819:Budesonide; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human; D019438:Ritonavir